All In Biotech

Drug Trial Radar · NCT01507922

Comparative Efficacy and Safety of Fenoverine

Comparative Efficacy and Safety of Fenoverine and Trimebutine Maleate in Irritable Bowel Syndrome; A Randomized Double-blind Parallel Multi-center Phase IV Trial

Last checked: Nov 20, 2026Latest source record: Dec 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 186 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

186

Planned (sponsor's estimate)

Start

Dec 2011

Primary completion

Mar 2013

Study completion Jun 2013

Sponsor

Lead sponsor
Bukwang PharmaceuticalIndustry
Sponsor type
Industry
First posted
Jan 11, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It is a randomized double-blind parallel phase IV study to compare Fenoverine and Trimebutine maleate in the efficacy and safety. Study Hypothesis: Fenoverine is non-inferior to Trimebutine maleate in its efficacy and safety.

Conditions

  • Irritable Bowel Syndrome

Interventions

  • FenoverineDrug

    Fenoverine 100mg three times a day for 8 weeks

  • TimebutineDrug

    Timebutine maleate 150mg three times a day for 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the proportion of subjects with improvement in abdominal pain or discomfortTime frame: week 8

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Korea University Ansan Hospital

    Ansan, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, South Korea

  • Kangwon National University Hospital

    Chuncheon, South Korea

  • Gachon University Gil Hospital

    Incheon, South Korea

  • Inje University Seoul Paik Hospital

    Seoul, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.